首页> 外文期刊>Toxicon: An International Journal Devoted to the Exchange of Knowledge on the Poisons Derived from Animals, Plants and Microorganisms >Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru
【24h】

Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru

机译:针对巴西中间人蜘蛛的重组皮肤坏死蛋白产生的抗loxoscelic马血清中和来自秘鲁的Laxosceles laeta毒液的致死作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In this work, an anti-loxoscelic serum was produced by immunizing horses with a recombinant dermonecrotic protein from Loxosceles intermedia (rLiD1). Anti-rLiD1 antibodies were able to recognize different species of Loxosceles venoms by Western Blot and ELISA. The efficacy of anti-rLiD1 serum against the toxic effects of Loxosceles beta (Peru) venom was tested, showing that anti-rLiD1 serum can neutralize those effects. This study confirms that recombinant proteins can be good candidates to replace crude venoms for antivenom production. (C) 2014 Elsevier Ltd. All rights reserved.
机译:在这项工作中,通过用来自中间Loxosceles intermedia(rLiD1)的重组皮肤坏死蛋白对马进行免疫,产生了抗高脂血清。抗rLiD1抗体能够通过Western Blot和ELISA识别不同种类的蛇纹蛇毒。测试了抗rLiD1血清对抗Loxosceles beta(Peru)毒液的毒性作用的功效,表明抗rLiD1血清可以中和那些作用。这项研究证实,重组蛋白可以很好地替代用于生产抗蛇毒血清的粗毒液。 (C)2014 Elsevier Ltd.保留所有权利。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号